Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Methods in Molecular Medicine|February 15, 2011
Tau phosphorylation both in vitro and in cellsC H Reynolds, G M Gibb, S LovestoneJournal of Neurochemistry|April 1, 1997
Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau proteinC H Reynolds, M A Utton, G M Gibb, et al.Journal of Neurochemistry|July 1, 1997
Reactivating kinase/p38 phosphorylates tau protein in vitroC H Reynolds, A R Nebreda, G M Gibb, et al.Dialogues in Clinical Neuroscience|October 29, 2011
Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's diseaseS LovestoneJournal of Neurology|April 9, 1999
Early diagnosis and the clinical genetics of Alzheimer's diseaseS LovestoneThe British Journal of Psychiatry : the Journal of Mental Science|September 1, 1992
Periodic psychosis associated with the menstrual cycle and increased blink rateS LovestoneFEBS Letters|March 30, 2001
Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changesJ W Connell, G M Gibb, J C Betts, et al.FEBS Letters|November 30, 2000
Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase-3 beta identified by nano-electrospray mass spectrometryG M Gibb, J Pearce, J C Betts, et al.International Journal of Psychiatry in Clinical Practice|June 14, 2014
Muscarinic therapies in Alzheimer's disease; from palliative treatments to disease modificationS LovestoneThe Biochemical Journal|May 1, 1997
Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assemblyM A Utton, A Vandecandelaere, U Wagner, et al.Pageof 16